Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540.

Adeola Y OlukosiOlusola AjibayeOmowunmi OmoniwaOlusola OresanyaAina O OluwagbemigaChinazo UjujuMichael EkholuenetaleKolawole MaxwellColin J SutherlandJames K TibenderanaKhalid B Beshir

Published in: The Journal of antimicrobial chemotherapy (2023)

Our data show that both states are suitable for SP-PMC implementation and, based on this finding, SP-PMC was implemented in Osun in 2022. Continuous monitoring of 540E will be required to ensure the chemoprevention effectiveness of SP in Nigeria.

Keyphrases

randomized controlled trial
primary care
healthcare
systematic review
risk factors
single cell
electronic health record
big data
machine learning